Stay updated on Obeticholic Acid in NASH Clinical Trial
Sign up to get notified when there's something new on the Obeticholic Acid in NASH Clinical Trial page.
Latest updates to the Obeticholic Acid in NASH Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe Publications section now notes that items are automatically filled in from PubMed, and the page revision indicator shows Revision: v3.3.2.SummaryDifference0.0%
- Check28 days agoChange DetectedAdded related topics 'Non-alcoholic fatty liver disease' and 'MedlinePlus Genetics'; removed the government funding status notice.SummaryDifference0.1%
- Check35 days agoChange DetectedRemoved the related topics 'Non-alcoholic fatty liver disease' and 'MedlinePlus Genetics' from the page's related topics. This affects metadata and discoverability but leaves the study details, locations, and eligibility unchanged.SummaryDifference0.0%
- Check42 days agoChange DetectedNo significant changes detected in the page content. The study overview, eligibility criteria, outcomes, and location listings appear unchanged from the previous view.SummaryDifference0.1%
- Check63 days agoChange DetectedAdded a new MedlinePlus Genetics topic: Non-alcoholic fatty liver disease; no deletions were present.SummaryDifference0.1%
- Check71 days agoChange DetectedUpdated page now includes a government-operating-status notice and a v3.2.0 revision tag; removed the non-alcoholic fatty liver disease topic under MedlinePlus Genetics and the older v3.1.0 tag.SummaryDifference2%
Stay in the know with updates to Obeticholic Acid in NASH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Obeticholic Acid in NASH Clinical Trial page.